Life Sciences

Translation Partnerships with Life Science Companies

OmniLingua Worldwide understands the scope, investment, and time it takes to bring a medical device, medicine, or healthcare service to the global healthcare marketplace.

Mistakes in translation are not just costly and damaging to your reputation. They can also substantially delay new product launches and harm brand recognition. Know this: At OmniLingua, you’ll have a partner that is truly committed to providing precise documentation—and minimizing risk.

OmniLingua is TÜV-certified to several ISO standards and has been partnering with Life Sciences companies as a localization service provider for over 20 years. We have supported our clients in developing mature localization systems that provide timely delivery of clinical study content, localized product software, user documentation, packaging and labeling, website, training and marketing content in more than 120 language combinations.


OmniLingua specializes in support for global clinical trials. Through these services, solutions and processes, we are ready to contribute to your success in the global healthcare market.

1. We offer a secure portal for managing the localization of medical safety reports from global multi-site clinical trials.

2. Our team of expert linguists represents more than 120 language combinations—both into and from English.

3. We have robust HIPAA-compliant processes and practice GCP (Good Clinical Practice) for all Life Science project types.

OmniLingua Life Sciences Content

Take advantage of our regulatory expertise and proven processes for the Life Sciences industry.

CONTACT US FOR A QUOTE

Our Partners:

GALA Logo ATA Logo TAUS

Ready to get started? Contact us today:

+1 319 365 8565 | info@omnilingua.com | Request a Quote

Big News from Ingenuiti

BIG NEWS FROM INGENUITI

Ingenuiti and its wholly-owned subsidiary OmniLingua will align and operate as one brand moving forward. As part of the brand alignment, a new website has been launched.

The new site is located at https://www.ingenuiti.com.

Moving forward, all the information regarding both companies can be found there, and this website will be closed on May 2nd, 2022.

You will be automatically redirected to the new site in 30 seconds.